HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical and molecular features of acute promyelocytic leukemia with variant retinoid acid receptor fusions.

AuthorsLijun Wen, Yang Xu, Li Yao, Nana Wang, Qinrong Wang, Tianhui Liu, Jinlan Pan, Jiannong Cen, Huifeng Zhou, Miao Miao, Yang W Shao, Xiaonan Wang, Xiaoxia Wang, Changgeng Ruan, Depei Wu, Suning Chen
JournalHaematologica (Haematologica) Vol. 104 Issue 5 Pg. e195-e199 (05 2019) ISSN: 1592-8721 [Electronic] Italy
PMID30237272 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Oncogene Proteins, Fusion
  • RARA protein, human
  • Receptors, Retinoic Acid
  • Retinoic Acid Receptor alpha
  • promyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Child
  • Child, Preschool
  • Chromosomes, Human, Pair 15 (genetics)
  • Chromosomes, Human, Pair 17 (genetics)
  • Female
  • Follow-Up Studies
  • Humans
  • Leukemia, Promyelocytic, Acute (genetics, pathology)
  • Male
  • Middle Aged
  • Oncogene Proteins, Fusion (genetics)
  • Prognosis
  • Receptors, Retinoic Acid (genetics)
  • Retinoic Acid Receptor alpha (genetics)
  • Retrospective Studies
  • Survival Rate
  • Translocation, Genetic
  • Young Adult
  • Retinoic Acid Receptor gamma

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: